Human variability in response to medication is an impediment to successful
drug treatment, as it makes good clinical response and avoidance of side ef
fects difficult to predict. Much of this variability is genetic in origin,
as inheritance results in differences in the way drugs are metabolized and
act on their receptors in the body. There are two possible ways of avoiding
this, either by designing future drugs which are not subject to the vagari
es of human metabolism, or by pharmacogenetics, i.e. determining those gene
tic factors which affect response. Pharmacogenetics looks for inherited dif
ferences between responders and non-responders (or those with and without a
particular side effect) to a given medication so that the mechanisms of va
riability can be understood. Current research is aimed at developing prescr
ibing strategies of the future which will use simple genetic tests to deter
mine which drug is most suitable for a given patient.